Latest News for: biib

Edit

Biogen (BIIB) Stock Trades Up, Here Is Why

The Call 19 Dec 2025
What Happened?. Shares of biotech company Biogen (NASDAQ. BIIB) jumped 2.8% in the morning session after RBC Capital reiterated an "Outperform" rating and a $210 price target on the stock, naming it a top large-cap pick for 2026 ... More News. View More ... .
Edit

Biogen (NASDAQ:BIIB) Beats Q3 Sales Expectations

The Call 30 Oct 2025
BIIB) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 2.8% year on year to $2.53 billion ... Biogen (BIIB) Q3 CY2025 Highlights. ... BIIB) develops and markets therapies ...
Edit

Q3 2025 BIIB Earnings Press Release FINAL (Biogen Inc)

Public Technologies 30 Oct 2025
). Press Release Cambridge, Mass. - October 30, 2025 ... Delivered 67% year-over-year growth across launch products in Alzheimer's disease, rare disease, and postpartum depression ... U.S ... Biogen Inc ... BIIB) today reported third quarter 2025 financial results ... △.
Edit

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

The Call 29 Oct 2025
Biotech company Biogen (NASDAQ. BIIB) will be announcing earnings results this Thursday before market open. Here’s what to look for ... Is Biogen a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... More News ... .
Edit

BIIB Stock: Is Biogen Still A Buy After The 14% Spike?

Forbes 03 Oct 2025
The company’s market value has increased by approximately $3.3 billion over the past 5 days, bringing its current market capitalization to around $23 billion ... .
  • 1

Article Search

tools
×
×
×
×